Research Analysts Set Expectations for Ascend Wellness Holdings, Inc.’s Q3 2024 Earnings (OTC:AAWH)

Ascend Wellness Holdings, Inc. (OTC:AAWH) – Equities researchers at Echelon Wealth Partners reduced their Q3 2024 EPS estimates for shares of Ascend Wellness in a research report issued on Tuesday, May 7th. Echelon Wealth Partners analyst A. Semple now anticipates that the company will earn ($0.04) per share for the quarter, down from their prior forecast of ($0.03). The consensus estimate for Ascend Wellness’ current full-year earnings is ($0.15) per share. Echelon Wealth Partners also issued estimates for Ascend Wellness’ FY2024 earnings at ($0.17) EPS.

Separately, Needham & Company LLC reissued a “hold” rating on shares of Ascend Wellness in a report on Tuesday.

Ascend Wellness Price Performance

Ascend Wellness stock opened at $1.32 on Friday. The company has a market cap of $272.83 million, a price-to-earnings ratio of -5.50 and a beta of 1.95. Ascend Wellness has a 12 month low of $0.46 and a 12 month high of $1.82. The company has a current ratio of 2.47, a quick ratio of 1.44 and a debt-to-equity ratio of 2.08. The business’s 50 day simple moving average is $1.27 and its 200 day simple moving average is $1.27.

About Ascend Wellness

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.